KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CareDx (CDNA) EBITDA (2016 - 2026)

CareDx's EBITDA history spans 14 years, with the latest figure at $1.2 million for Q1 2026.

  • On a quarterly basis, EBITDA rose 108.96% to $1.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$16.2 million, a 132.45% decrease, with the full-year FY2025 number at -$30.8 million, down 175.51% from a year prior.
  • EBITDA hit $1.2 million in Q1 2026 for CareDx, up from -$6.0 million in the prior quarter.
  • Over the last five years, EBITDA for CDNA hit a ceiling of $84.4 million in Q4 2024 and a floor of -$122.6 million in Q4 2023.
  • Historically, EBITDA has averaged -$15.8 million across 5 years, with a median of -$17.3 million in 2022.
  • Biggest five-year swings in EBITDA: crashed 2120.63% in 2022 and later soared 168.81% in 2024.
  • Tracing CDNA's EBITDA over 5 years: stood at -$19.1 million in 2022, then plummeted by 541.38% to -$122.6 million in 2023, then surged by 168.81% to $84.4 million in 2024, then plummeted by 107.16% to -$6.0 million in 2025, then surged by 119.83% to $1.2 million in 2026.
  • Business Quant data shows EBITDA for CDNA at $1.2 million in Q1 2026, -$6.0 million in Q4 2025, and -$246000.0 in Q3 2025.